Driving Growth and Innovation in Inpatient Rehabilitation
Outstanding Financial Performance in Q2 2026
Encompass Health announced a successful second quarter in 2026, showcasing impressive financial growth across key metrics. The company reported a net operating revenue of $1.597 billion, marking a 9.6% year-over-year increase. This surge was primarily fueled by an expansion in discharge volumes and enhanced patient pricing strategies. Adjusted EBITDA climbed to $348 million, a 9.2% rise, reflecting significant operational efficiencies despite a reduction in net provider tax impact. Adjusted Earnings Per Share (EPS) saw a 10.7% increase, reaching $1.55, up from $1.40 in the same period of 2025.
Strategic Expansion and Capacity Enhancement
The company continued its strategic expansion initiatives, adding new facilities and increasing bed capacity to meet the growing demand for inpatient rehabilitation services. In the second quarter, Encompass Health opened a new 50-bed hospital in Concordville, Pennsylvania, and a 40-bed facility in Loganville, Georgia, the latter being its eighth joint venture with Piedmont. An additional 10 beds were integrated into existing hospitals. For the first half of 2026, the company launched three new hospitals, contributing 139 beds, and expanded existing facilities by 54 beds. Plans are underway to open five more hospitals, adding 250 beds, and to further expand existing hospitals by 100 to 150 beds by year-end. A robust pipeline of 13 new hospital projects, totaling 606 beds, is also in development, with future announcements expected to include small-format hospitals.
Leveraging North Carolina’s Market Opportunities
The repeal of Certificate of Need (CON) laws for inpatient rehabilitation care in North Carolina, effective October 1, presents a significant growth opportunity for Encompass Health. The company views this as a positive development for North Carolina residents, enhancing access to essential rehabilitation services. Recognizing the state’s favorable population growth and demographic trends, particularly a large underserved market for Inpatient Rehabilitation Facility (IRF) services, Encompass Health has prioritized 15 markets for development. Three real estate parcels are already under contract, with the first new hospital in North Carolina anticipated to open in late 2028 or early 2029. This strategic move aims to replicate the success observed after the CON repeal in Florida.
Enhancing Clinical Staff Development and Retention
Encompass Health is committed to investing in its clinical workforce through professional growth and development programs, notably clinical career ladders. These initiatives provide nurses with support to achieve advanced licenses and certifications, such as the Certified Rehabilitation Registered Nurse (CRRN) designation. Such programs have proven effective in reducing nursing turnover, which reached its lowest level in over 12 years at 19% annually through Q2. Participating staff in the clinical ladder program showed an even lower turnover rate of 5%. This focus on staff development also contributes to improved patient outcomes and a reduced reliance on costly premium labor.
Advancements in Payer Relations and Patient Acuity
Despite ongoing challenges with pre-authorization denials from Medicare Advantage (MA) plans, Encompass Health’s admit and appeal pilot program has shown promising results. With an 89% success rate on 144 fully adjudicated cases, the program demonstrates the appropriateness of care for patients initially denied access. The company is evaluating scaling this program portfolio-wide. Furthermore, the company reported a 3.9% increase in net revenue per discharge, driven by higher patient acuity and growth in medically complex categories like stroke and brain injury. The Centers for Medicare & Medicaid Services (CMS) 2027 IRF final rule is expected to further boost net revenue per discharge for Medicare patients by approximately 2.3% starting October 1, 2026.
Financial Outlook and Shareholder Returns
Following the strong Q2 performance, management has once again raised its full-year 2026 financial guidance. The revised outlook projects net operating revenue between $6.41 billion and $6.49 billion, adjusted EBITDA between $1.365 billion and $1.395 billion, and adjusted EPS ranging from $6.02 to $6.25. The company’s balance sheet remains strong, with a net leverage of 1.9x at quarter-end, supporting both capacity growth and shareholder returns. The board of directors increased the share repurchase authorization to $1 billion and approved a higher quarterly dividend of $0.21 per share, reflecting confidence in the company’s financial health and future prospects.
Operational Efficiencies and Technology Integration
Encompass Health is continuously improving operational efficiencies, as evidenced by a 3.4% increase in Salaries, Wages, and Benefits (SWB) per Full-Time Equivalent (FTE), partly offset by a decline in premium labor costs. Contract labor as a percentage of total FTEs improved to 1.1%, down 20 basis points from the prior year. The company is also making strategic technology investments, including AI initiatives and a partnership with Palantir, to enhance clinical workflows and administrative processes. These innovations are expected to drive further efficiencies and improve patient care by proactively identifying potential risks and streamlining operations.
